HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jan 2023| TMR1802B| Transparency

Report Highlights

HIV/AIDS Diagnostics Market – Scope of Report

TMR’s report on the global HIV/AIDS diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global HIV/AIDS diagnostics market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HIV/AIDS diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the HIV/AIDS diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global HIV/AIDS diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global HIV/AIDS diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global HIV/AIDS diagnostics market.

The report delves into the competitive landscape of the global HIV/AIDS diagnostics market. Key players operating in the global HIV/AIDS diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global HIV/AIDS diagnostics market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market HIV/AIDS diagnostics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
    • WorldWideScience.org
    • Elsevier, Inc.
    • National Institutes of Health (NIH)
    • PubMed
    • NCBI
    • Department of Health Care Service
  • Trade Data Sources
    • Trade Map
    • UN Comtrade
    • Trade Atlas
  • Company Information
    • OneSource Business Browser
    • Hoover’s
    • Factiva
    • Bloomberg
  • Mergers & Acquisitions
    • Thomson Mergers & Acquisitions
    • MergerStat
    • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

 

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 9.30%
Units considered $ Million
Segments covered By Product, By Test Type, By End User, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Companies studied
  • Hologic, Inc.,
  • Siemens Healthcare GmbH,
  • Abbott,
  • Bio-Rad Laboratories, Inc.,
  • F. Hoffmann-La Roche Ltd.,
  • OraSure Technologies, Inc.,
  • Chembio Diagnostics, Inc.,
  • Becton, Dickinson and Company
  • Danaher Corporation

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 2 : Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 3 : Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 4 : Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 6 : North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 7 : North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 8 : North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 9 : Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 10 : Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 11 : Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 12 : Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 13 : Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 15 : Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 16 : Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 17 : Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 18 : Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 19 : Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 20 : Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 21 : Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 22 : Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 23 : Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
  • Table 24 : Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Figure 1 : Market Share, By Product
  • Figure 2 : Market Share, By Test Type
  • Figure 3 : Market Share, By End-user
  • Figure 4 : Market Share, By Region
  • Figure 5 : Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 6 : Global HIV/AIDS Diagnostics Market Value Share, by Product (2021)
  • Figure 7 : Global HIV/AIDS Diagnostics Market Value Share, by End-user (2021)
  • Figure 8 : Global HIV/AIDS Diagnostics Market Value Share, by Test Type (2021)
  • Figure 9 : Global HIV/AIDS Diagnostics Market Value Share, by Region (2021)
  • Figure 10 : Global HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 11 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Kits and Reagents, 2017–2031
  • Figure 12 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Instruments, 2017–2031
  • Figure 13 : Global HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 14 : Global HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 15 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Nucleic Acid Tests, 2017–2031
  • Figure 16 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Rapid Tests (POC), 2017–2031
  • Figure 17 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by ELISA, 2017–2031
  • Figure 18 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Others, 2017–2031
  • Figure 19 : Global HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 20 : Global HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 21 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017–2031
  • Figure 22 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017–2031
  • Figure 23 : Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Academic and Research Institutes, 2017–2031
  • Figure 24 : Global HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 25 : Global HIV/AIDS Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 26 : Global HIV/AIDS Diagnostics Market Attractiveness, by Region, 2022-2031
  • Figure 27 : North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 28 : North America HIV/AIDS Diagnostics Market Value Share (%), by Country, 2021 and 2031
  • Figure 29 : North America HIV/AIDS Diagnostics Market Attractiveness, by Country, 2022–2031
  • Figure 30 : North America HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 31 : North America HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 32 : North America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 33 : North America HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 34 : North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 35 : North America HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 36 : Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 37 : Europe HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 38 : Europe HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022–2031
  • Figure 39 : Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 40 : Europe HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 41 : Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 42 : Europe HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 43 : Europe HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 44 : Europe HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 45 : Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 46 : Asia Pacific HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 47 : Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022–2031
  • Figure 48 : Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 49 : Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 50 : Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 51 : Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 52 : Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 53 : Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 54 : Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 55 : Latin America HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 56 : Latin America HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022–2031
  • Figure 57 : Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 58 : Latin America HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 59 : Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 60 : Latin America HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 61 : Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 62 : Latin America HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 63 : Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 64 : Middle East & Africa HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 65 : Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022–2031
  • Figure 66 : Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 67 : Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022–2031
  • Figure 68 : Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 69 : Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022–2031
  • Figure 70 : Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 71 : Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022–2031
  • Figure 72 : Global HIV/AIDS Diagnostics Market Share Analysis, by Company, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

HIV/AIDS Diagnostics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Date - Sep 2019
  • Code - TMR1802A

HIV/AIDS Diagnostics Market - Scope of the Report

[202 Pages Report] A new study on the global HIV/AIDS diagnostics market was published by Transparency Market Research (TMR). It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the HIV/AIDS diagnostics market. TMR’s study offers important information ...

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.